scholarly journals Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

2011 ◽  
Vol 12 (7) ◽  
pp. 642-653 ◽  
Author(s):  
Richard A Adams ◽  
Angela M Meade ◽  
Matthew T Seymour ◽  
Richard H Wilson ◽  
Ayman Madi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Combination Chemotherapy ◽  
Advanced Colorectal Cancer ◽  
Line Treatment ◽  
First Line ◽  
Phase 3 ◽  
First Line Treatment

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

2014 ◽  
Vol 15 (10) ◽  
pp. 1065-1075 ◽  
Author(s):  
Volker Heinemann ◽  
Ludwig Fischer von Weikersthal ◽  
Thomas Decker ◽  
Alexander Kiani ◽  
Ursula Vehling-Kaiser ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Line Treatment ◽  
First Line ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
First Line Treatment

scholarly journals First-line treatment with modified FOLFOXIRI plus bevacizumab in patients with locally advanced colorectal cancer

2020 ◽  
Vol 28 (1) ◽  
pp. 44-48 ◽  
Author(s):  
Yasufumi Yamada ◽  
Kazuhiko Yoshimatsu ◽  
Hajime Yokomizo ◽  
Sachiyo Okayama ◽  
Hiroyuki Maeda ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Advanced Colorectal Cancer ◽  
Locally Advanced ◽  
Line Treatment ◽  
First Line ◽  
Locally Advanced Colorectal Cancer ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document